G Medical Innovations Holdings Ltd (GMVD) Actualités

Form S-8 - Securities to be offered to employees in employee benefit plans

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   Report of...

G Medical Innovations Holdings Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification

Rehovot, Israel, May 19, 2023 (GLOBE NEWSWIRE) --  G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   Report of...

Annual and Transition Report (foreign Private Issuer) (20-f)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549   FORM 20-F   ANNUAL...

G Medical Innovations Holdings Ltd. Announces Receipt of Nasdaq Hearings Panel’s Decision to Grant Exception for Continued Listing

Rehovot, Israel, May 15, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the...

Amended Statement of Ownership (sc 13g/a)

THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the...

Notification That Form 20-f Will Be Submitted Late (nt 20-f)

        UNITED STATES OMB APPROVAL   SECURITIES AND EXCHANGE COMMISSION OMB Number:...

G MEDICAL UPDATES ON PATIENT ENROLLMENT GROWTH FOR ITS HOME MONITORING SERVICES OF 194% FROM JANUARY THROUGH APRIL 2023, AS COMPARED TO THE SAME PERIOD IN 2022

Rehovot, Israel, April 18, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the...

Amended Statement of Beneficial Ownership (sc 13d/a)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13D (Amendment No...

Statement of Ownership (sc 13g)

THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the...

Initial Statement of Beneficial Ownership (3)

FORM 3          UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

G Medical Innovations Holdings Ltd. Announces Closing of Public Offering

Rehovot, Israel, April 04, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”), a global leader in...

Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)

Filed Pursuant to Rule 424(b)(4) Registration No. 333-269496   5,470,000 Ordinary Shares 6,530,000 Pre-Funded Warrants...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:March 31, 2023...